메뉴 건너뛰기




Volumn 40, Issue 2, 2004, Pages 133-145

Lipid-based formulations of amphotericin B

Author keywords

[No Author keywords available]

Indexed keywords

1 [2 (2,4 DIFLUOROPHENYL) 2 HYDROXY 1 METHYL 3 (1H 1,2,4 TRIAZOL 1 YL)PROPYL] 3 [4 (1H TETRAZOL 1 YL)PHENYL] 2 IMIDAZOLIDINONE; 1,2,4 TRIAZOLE 3 THIONE DERIVATIVE; 4 [4 [5 [2 (2,4 DIFLUOROPHENYL) 2 HYDROXY 1 METHYL 3 (1H 1,2,4, TRIAZOL 1 YL)PROPYLTHIO] 1,3 DIOXAN 2 YL] 1,3 BUTADIENYL] 3 FLUOROBENZONITIRLE; AMPHOTERICIN B; AMPHOTERICIN B CHOLESTEROL SULFATE; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B INTRALIPID; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; AUREOBASIDIN A; FLUCONAZOLE; FLUCYTOSINE; GL 48656; ITRACONAZOLE; MULTILAMELLAR LIPOSOMAL AMPHOTERICIN B; NANOPARTICLE; POSACONAZOLE; RAVUCONAZOLE; SMALL UNILAMELLAR LIPOSOMAL AMPHOTERICIN B; UNCLASSIFIED DRUG; VORICONAZOLE; YATAKAMYCIN;

EID: 1642397172     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.2004.40.2.799425     Document Type: Review
Times cited : (57)

References (93)
  • 1
    • 0026050590 scopus 로고
    • Epidemiology and pathogenesis of systemic fungal infection in the immunocompromised host
    • Denning, D.W. Epidemiology and pathogenesis of systemic fungal infection in the immunocompromised host. J Antimicrob Chemother 1991, 28 (Suppl. B): 1-16.
    • (1991) J Antimicrob Chemother , vol.28 , Issue.SUPPL. B , pp. 1-16
    • Denning, D.W.1
  • 2
    • 0025256091 scopus 로고
    • Amphotericin B. 30 Years of clinical experience
    • Gallis, H.A., Drew, R.H., Pickarrd, W.W. Amphotericin B. 30 years of clinical experience. Rev Infect Dis 1990, 12: 308-29.
    • (1990) Rev Infect Dis , vol.12 , pp. 308-329
    • Gallis, H.A.1    Drew, R.H.2    Pickarrd, W.W.3
  • 3
    • 0027960239 scopus 로고
    • Visceral leishmaniasis is more prevalent and more problematic
    • Baily, G.G., Nandy, A. Visceral leishmaniasis is more prevalent and more problematic. J Infect 1994, 29: 241-7.
    • (1994) J Infect , vol.29 , pp. 241-247
    • Baily, G.G.1    Nandy, A.2
  • 4
    • 0025953653 scopus 로고
    • Liposmal amphotericin B in the treatment of visceral (Leishmaniasis)
    • Croft, S.L., Davidson, R.N., Thornton, E.A. Liposmal amphotericin B in the treatment of visceral (Leishmaniasis). J Antimicrob Agents 1991, 28 (Suppl. B): 111-8.
    • (1991) J Antimicrob Agents , vol.28 , Issue.SUPPL. B , pp. 111-118
    • Croft, S.L.1    Davidson, R.N.2    Thornton, E.A.3
  • 5
    • 0030706106 scopus 로고    scopus 로고
    • Aspergillus and candida infections in bone marrow transplantation: Progress and controversies
    • Revankar, S.G., Patterson, T.F. Aspergillus and candida infections in bone marrow transplantation: Progress and controversies. Infect Dis Clin Pract 1997, 6: 506-12.
    • (1997) Infect Dis Clin Pract , vol.6 , pp. 506-512
    • Revankar, S.G.1    Patterson, T.F.2
  • 6
    • 0028919545 scopus 로고
    • Pretreatment regimens for adverse events related to infusion of amphotericin B
    • Goodwin, S.D., Cleary, J.D., Walawander, C.A. et al. Pretreatment regimens for adverse events related to infusion of amphotericin B. Clinical Infect Dis 1995, 20: 755-61.
    • (1995) Clinical Infect Dis , vol.20 , pp. 755-761
    • Goodwin, S.D.1    Cleary, J.D.2    Walawander, C.A.3
  • 7
    • 0033376314 scopus 로고    scopus 로고
    • Clinical significance of nephrotoxicity in patients treated with amphotericin B for suspected or proven aspergillosis
    • Windgard, J.R., Kubilis, P., Lee, L. et al. Clinical significance of nephrotoxicity in patients treated with amphotericin B for suspected or proven aspergillosis. Clin Infect Dis 1999, 29: 1402-7.
    • (1999) Clin Infect Dis , vol.29 , pp. 1402-1407
    • Windgard, J.R.1    Kubilis, P.2    Lee, L.3
  • 8
    • 0346649983 scopus 로고
    • Mechanism of action of an anti-candida drug: Amphotericin B and its derivatives
    • Prasad, R. (Ed.) Springer-Verlag KB, Berlin
    • Bolard, J. Mechanism of action of an anti-candida drug: amphotericin B and its derivatives. In: Candida albicans. Cellular and molecular biology. Prasad, R. (Ed.) Springer-Verlag KB, Berlin 1991, 213-38.
    • (1991) Candida Albicans. Cellular and Molecular Biology , pp. 213-238
    • Bolard, J.1
  • 10
    • 0026677494 scopus 로고
    • Liposomes: Realizing their promise
    • Bangham, A.D. Liposomes: realizing their promise. Hosp Pract 1992, 27: 51-62.
    • (1992) Hosp Pract , vol.27 , pp. 51-62
    • Bangham, A.D.1
  • 12
    • 0028954312 scopus 로고
    • Amphotericin B lipid complex
    • Fromtling, R.A. Amphotericin B lipid complex. Drugs Fut 1995, 20: 129-34.
    • (1995) Drugs Fut , vol.20 , pp. 129-134
    • Fromtling, R.A.1
  • 13
    • 0027314254 scopus 로고
    • Amphotericin B its delivery by liposomal and lipid formulation
    • Gates, C., Pinney, R.J. Amphotericin B and its delivery by liposomal and lipid formulation. J Clin Pharm Ther 1993, 18: 147-53.
    • (1993) J Clin Pharm Ther , vol.18 , pp. 147-153
    • Gates, C.1    Pinney, R.J.2
  • 14
    • 0028308848 scopus 로고
    • Liposomal amphotericin B, AmBisome
    • Hay, R.J. Liposomal amphotericin B, AmBisome. J Infect 1994, 28 (Suppl. 1): 35-43.
    • (1994) J Infect , vol.28 , Issue.SUPPL. 1 , pp. 35-43
    • Hay, R.J.1
  • 15
    • 0028343094 scopus 로고
    • Alternative modalities of administering amphotericin B: Current issues
    • Meunier, F. Alternative modalities of administering amphotericin B: Current issues. J Infect 1994, 28 (Suppl. 1): 51-6.
    • (1994) J Infect , vol.28 , Issue.SUPPL. 1 , pp. 51-56
    • Meunier, F.1
  • 16
    • 0026437668 scopus 로고
    • Effects of aggregation and solvent on the toxicity of amphotericin B to human erythrocytes
    • Legrand, P., Romero, E.A., Cohers, B.E., Bolard, J. Effects of aggregation and solvent on the toxicity of amphotericin B to human erythrocytes. Antimicrob Agents Chemother 1992, 36: 2518-22.
    • (1992) Antimicrob Agents Chemother , vol.36 , pp. 2518-2522
    • Legrand, P.1    Romero, E.A.2    Cohers, B.E.3    Bolard, J.4
  • 17
    • 0025808089 scopus 로고
    • One-sided action of amphotericin B on cholesterol containing membranes is determined by its self association in the medium
    • Bolard, J., Legrand, P., Heitz, F., Cybulska, B. One-sided action of amphotericin B on cholesterol containing membranes is determined by its self association in the medium. Biochemistry 1991, 30: 5707-15.
    • (1991) Biochemistry , vol.30 , pp. 5707-5715
    • Bolard, J.1    Legrand, P.2    Heitz, F.3    Cybulska, B.4
  • 18
    • 0023554369 scopus 로고
    • The effect of azole and polyene antifungals on the plasma membrane enzymes of candida albicans
    • Surarit, R., Stepherd, M.G. The effect of azole and polyene antifungals on the plasma membrane enzymes of candida albicans. J Med Vet Mycol 1987, 25: 403-9.
    • (1987) J Med Vet Mycol , vol.25 , pp. 403-409
    • Surarit, R.1    Stepherd, M.G.2
  • 20
    • 0020353723 scopus 로고
    • Association of the polyene antibiotic amphotericin B with phospholipid vesicles: Perturbation by temperature changes
    • Bolard, J., Cheron, M. Association of the polyene antibiotic amphotericin B with phospholipid vesicles: Perturbation by temperature changes. Can J Biochem 1982, 60: 782-9.
    • (1982) Can J Biochem , vol.60 , pp. 782-789
    • Bolard, J.1    Cheron, M.2
  • 21
    • 0021821734 scopus 로고
    • Effect of elevation of serum cholesterol and administration of amphotericin B complexed to lipoproteins on amphotericin B-induced toxicity in rabbits
    • Koldin, M.H., Kohayashi, G.S., Brajtburg, J., Medoff, G. Effect of elevation of serum cholesterol and administration of amphotericin B complexed to lipoproteins on amphotericin B-induced toxicity in rabbits. Antimicrob Agents chemother 1985, 28: 144-5.
    • (1985) Antimicrob Agents Chemother , vol.28 , pp. 144-145
    • Koldin, M.H.1    Kohayashi, G.S.2    Brajtburg, J.3    Medoff, G.4
  • 22
    • 0026355895 scopus 로고
    • Inhibition of the interaction between lipoproteins and amphotericin B by some delivery systems
    • Barwicz, J., Gareau, R., Audet, A., Morisset, A., Villiard, J., Gruda, I. Inhibition of the interaction between lipoproteins and amphotericin B by some delivery systems. Biochem Biophys Res Commun 1991, 181: 722-8.
    • (1991) Biochem Biophys Res Commun , vol.181 , pp. 722-728
    • Barwicz, J.1    Gareau, R.2    Audet, A.3    Morisset, A.4    Villiard, J.5    Gruda, I.6
  • 23
    • 0021686735 scopus 로고
    • Enhancement of amphotericin B selectively by antibiotic incorporation into gel state vesicles. A circular dichroism and permeability study
    • Vertut-Croquin, A., Bolord, J., Gary-Bobo, C. Enhancement of amphotericin B selectively by antibiotic incorporation into gel state vesicles. A circular dichroism and permeability study. Biochem Biophys Res Commun 1984, 125: 360-5.
    • (1984) Biochem Biophys Res Commun , vol.125 , pp. 360-365
    • Vertut-Croquin, A.1    Bolord, J.2    Gary-Bobo, C.3
  • 24
    • 0021847339 scopus 로고
    • Transfer of amphotericin B from gel state vesicles to mycoplasma cells: Biphasic action on potassium transport and permeability
    • Vertut-Croquin, A., Bolord, A., Gary-Bobo, C. Transfer of amphotericin B from gel state vesicles to mycoplasma cells: Biphasic action on potassium transport and permeability. Antimicrob Agents Chemother 1985, 28: 167-71.
    • (1985) Antimicrob Agents Chemother , vol.28 , pp. 167-171
    • Vertut-Croquin, A.1    Bolord, A.2    Gary-Bobo, C.3
  • 25
    • 0018881828 scopus 로고
    • Comparative properties and methods of preparations of lipid vesicles (liposomes)
    • Szoka, F. Jr., Papahadjopoulos, D. Comparative properties and methods of preparations of lipid vesicles (liposomes). Ann Rev Biophys Bioengineer 1980, 9: 457-508.
    • (1980) Ann Rev Biophys Bioengineer , vol.9 , pp. 457-508
    • Szoka Jr., F.1    Papahadjopoulos, D.2
  • 26
    • 0015795402 scopus 로고
    • Phase transitions in phospholipid vesicles. Florescence polarization and permeability measurements concerning the effect of temperature and cholesterol
    • Papahadjopoulos, D., Jacobson, K., Nir, S., Isac, T. Phase transitions in phospholipid vesicles. Florescence polarization and permeability measurements concerning the effect of temperature and cholesterol. Biochim Biophys Act 1973, 311: 330-48.
    • (1973) Biochim Biophys Act , vol.311 , pp. 330-348
    • Papahadjopoulos, D.1    Jacobson, K.2    Nir, S.3    Isac, T.4
  • 27
    • 0022862167 scopus 로고
    • How do the polyene macrolide antibiotics affect the cellular membrane properties?
    • Bolard, J. How do the polyene macrolide antibiotics affect the cellular membrane properties? Biochim Biophy Acta 1986, 864: 257-304.
    • (1986) Biochim Biophy Acta , vol.864 , pp. 257-304
    • Bolard, J.1
  • 28
    • 0022439033 scopus 로고
    • Mode of action of clinically important antifungal drugs
    • Kerridge, D. Mode of action of clinically important antifungal drugs. Adv Microb Physiol 1986, 27: 1-72.
    • (1986) Adv Microb Physiol , vol.27 , pp. 1-72
    • Kerridge, D.1
  • 29
    • 0021750223 scopus 로고
    • Effect of surface curvature on the interaction of single lamellar phospholipid vesicles with aromatic and non aromatic heptane antibiotics
    • Bolard, J., Cheron, M., Mazer Ski, J. Effect of surface curvature on the interaction of single lamellar phospholipid vesicles with aromatic and non aromatic heptane antibiotics. Biochem Pharmacol 1984, 33: 3675-80.
    • (1984) Biochem Pharmacol , vol.33 , pp. 3675-3680
    • Bolard, J.1    Cheron, M.2    Mazer Ski, J.3
  • 31
    • 0024374196 scopus 로고
    • Physical biochemistry of a liposomal amphotericin B mixture used for patient treatment
    • Grant, C.W.M., Hamilton, K.S., Hamilton, K.D., Barber, K.R. Physical biochemistry of a liposomal amphotericin B mixture used for patient treatment. Biochim Biophys Acta 1989, 984: 11-20.
    • (1989) Biochim Biophys Acta , vol.984 , pp. 11-20
    • Grant, C.W.M.1    Hamilton, K.S.2    Hamilton, K.D.3    Barber, K.R.4
  • 32
    • 0021268461 scopus 로고
    • Liposome-encapsulated amphotericin B for treatment of disseminated candidiasis in neutropenic mice
    • Lopez-Berestein, G., Hopfer, R.L., Mehta, R., Mehta, K., Hersh, E.M., Juliano, R.L. Liposome-encapsulated amphotericin B for treatment of disseminated candidiasis in neutropenic mice. J Infect Dis 1984, 150: 278-83.
    • (1984) J Infect Dis , vol.150 , pp. 278-283
    • Lopez-Berestein, G.1    Hopfer, R.L.2    Mehta, R.3    Mehta, K.4    Hersh, E.M.5    Juliano, R.L.6
  • 33
    • 0021958862 scopus 로고
    • Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: A preliminary study
    • Lopez-Berestein, G., Fainstein, V., Hopfer, R. et al. Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: A preliminary study. J Infect Dis 1985, 151: 704-10.
    • (1985) J Infect Dis , vol.151 , pp. 704-710
    • Lopez-Berestein, G.1    Fainstein, V.2    Hopfer, R.3
  • 34
    • 0023157745 scopus 로고
    • Treatment of nepatosplenic candidiasis with liposomal - Amphotericin B
    • Lopez-Berestein, G., Bodey, G.P., Frankel, L.S., Mehta, K. Treatment of nepatosplenic candidiasis with liposomal - Amphotericin B. J Clin Oncol 1987, 5: 310-7.
    • (1987) J Clin Oncol , vol.5 , pp. 310-317
    • Lopez-Berestein, G.1    Bodey, G.P.2    Frankel, L.S.3    Mehta, K.4
  • 35
    • 0027316810 scopus 로고
    • Clinical experience with multilamellar liposomal amphotericin B in patients with proven and suspected fungal infection
    • Ralph, E.D., Barber, K.R., Grant, C.W.M. Clinical experience with multilamellar liposomal amphotericin B in patients with proven and suspected fungal infection. Scand J Infect Dis 1993, 23: 487-96.
    • (1993) Scand J Infect Dis , vol.23 , pp. 487-496
    • Ralph, E.D.1    Barber, K.R.2    Grant, C.W.M.3
  • 36
    • 0024592238 scopus 로고
    • Interaction of the polyene antibiotic amphotericin B with model membranes: Differences between small and large unilamellar vesicles
    • Milhaud, J., Hartmann, M.A., Bolard, J. Interaction of the polyene antibiotic amphotericin B with model membranes: Differences between small and large unilamellar vesicles. Biochimie 1989, 71: 49-56.
    • (1989) Biochimie , vol.71 , pp. 49-56
    • Milhaud, J.1    Hartmann, M.A.2    Bolard, J.3
  • 37
    • 0024160529 scopus 로고
    • Amphotericin B encapsulated in liposomes administered to cancer patients
    • Meunier, F., Sculier, J.P., Coune, A. et al. Amphotericin B encapsulated in liposomes administered to cancer patients. Ann NY Acad Sci 1988, 544: 598-610.
    • (1988) Ann NY Acad Sci , vol.544 , pp. 598-610
    • Meunier, F.1    Sculier, J.P.2    Coune, A.3
  • 38
    • 0024421096 scopus 로고
    • Pharmacokinetics of amphotericin B in patients receiving repeated intravenous high doses of amphotericin B entrapped into sonicated liposomes
    • Sculier, J.P., Delcroix, C., Brassinne, C., Laduron, C., Hollaert, C. Pharmacokinetics of amphotericin B in patients receiving repeated intravenous high doses of amphotericin B entrapped into sonicated liposomes. J Liposome Res 1989, 1: 151-66.
    • (1989) J Liposome Res , vol.1 , pp. 151-166
    • Sculier, J.P.1    Delcroix, C.2    Brassinne, C.3    Laduron, C.4    Hollaert, C.5
  • 39
    • 0025259609 scopus 로고
    • In-vitro evaluation of the antifungal activity of amphotericin B entrapped into liposomes during storage for one year
    • Heymans, C., Vander Auwera, P., Scalier, J.P. et al. In-vitro evaluation of the antifungal activity of amphotericin B entrapped into liposomes during storage for one year. J Antimicrob Chemother 1990, 25: 361-6.
    • (1990) J Antimicrob Chemother , vol.25 , pp. 361-366
    • Heymans, C.1    Vander Auwera, P.2    Scalier, J.P.3
  • 40
    • 0027324048 scopus 로고
    • Successful treatment of disseminated candidiasis resistant to amphotericin B by liposonal amphotericin B: A case report
    • Gokhale, P., Barapatre, R.J., Advani, S.H., Kshirsagar, N.A., Bandya, S.K. Successful treatment of disseminated candidiasis resistant to amphotericin B by liposonal amphotericin B: A case report. J Cancer Res Clin Oncol 1993, 119: 569-71.
    • (1993) J Cancer Res Clin Oncol , vol.119 , pp. 569-571
    • Gokhale, P.1    Barapatre, R.J.2    Advani, S.H.3    Kshirsagar, N.A.4    Bandya, S.K.5
  • 41
    • 0038548568 scopus 로고    scopus 로고
    • Management of Aspergillus osteomylitis: Report of liposomal amphotericin B and response to voriconazole in an immunocompetent host and literature review
    • Stratov, I., Korman, T.M., Johnson, P.D. Management of Aspergillus osteomylitis: Report of liposomal amphotericin B and response to voriconazole in an immunocompetent host and literature review. Eur J Clin Microbiol Infect Dis 2003, 22: 277-83.
    • (2003) Eur J Clin Microbiol Infect Dis , vol.22 , pp. 277-283
    • Stratov, I.1    Korman, T.M.2    Johnson, P.D.3
  • 42
    • 0036560408 scopus 로고    scopus 로고
    • Open label, randomised, comparative phase III safety and efficacy study with conventional amphotericin B and liposomal amphotericin B in patients with systemic fungal infection
    • Bodne, P.V., Kotwani, R.N., Kirodian, B.G., Kshirsagar, N.A., Pandya, S.K. Open label, randomised, comparative phase III safety and efficacy study with conventional amphotericin B and liposomal amphotericin B in patients with systemic fungal infection. J Assoc Physicians India 2002, 50: 662-70.
    • (2002) J Assoc Physicians India , vol.50 , pp. 662-670
    • Bodne, P.V.1    Kotwani, R.N.2    Kirodian, B.G.3    Kshirsagar, N.A.4    Pandya, S.K.5
  • 43
    • 0036234824 scopus 로고    scopus 로고
    • Drug delivery system of anti-fungal and parasitic agents
    • Maesaki, S. Drug delivery system of anti-fungal and parasitic agents. Curr Pharm Des 2002, 8: 433-40.
    • (2002) Curr Pharm Des , vol.8 , pp. 433-440
    • Maesaki, S.1
  • 44
    • 0019324697 scopus 로고
    • Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro
    • Kirby, C., Clarke, J., Gregariadis, G. Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro. Biochem J 1980, 186: 591-8.
    • (1980) Biochem J , vol.186 , pp. 591-598
    • Kirby, C.1    Clarke, J.2    Gregariadis, G.3
  • 45
    • 0030933186 scopus 로고    scopus 로고
    • The formation of amphotericin B ion channels in lipid bilayers
    • Fujii, G., Chang, J.E., Coley, T., Sreere, B. The formation of amphotericin B ion channels in lipid bilayers. Biochemistry 1997, 38: 4959-68.
    • (1997) Biochemistry , vol.38 , pp. 4959-4968
    • Fujii, G.1    Chang, J.E.2    Coley, T.3    Sreere, B.4
  • 46
    • 0029145597 scopus 로고
    • Liposomal antifungal battle for market share
    • Glasser, V. Liposomal antifungal battle for market share. BioTechnology 1995, 13: 728-9.
    • (1995) BioTechnology , vol.13 , pp. 728-729
    • Glasser, V.1
  • 47
    • 7844233666 scopus 로고    scopus 로고
    • Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia Associated invasive fungal infections
    • Alexander, C., Leenders, A.P., Simon Daener et al. Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia Associated invasive fungal infections. Brit J Haematol 1998, 103: 205-12.
    • (1998) Brit J Haematol , vol.103 , pp. 205-212
    • Alexander, C.1    Leenders, A.P.2    Daener, S.3
  • 48
    • 0027139351 scopus 로고
    • Development, characterization, efficacy and mode of action of AmBiosome, a unilamellar liposomal formulation of amphotericin B
    • Adler-Moore, J.P., Proffitt, R.J. Development, characterization, efficacy and mode of action of AmBiosome, a unilamellar liposomal formulation of amphotericin B. J Liposome Res 1993, 393: 429-50.
    • (1993) J Liposome Res , vol.393 , pp. 429-450
    • Adler-Moore, J.P.1    Proffitt, R.J.2
  • 49
    • 0027980052 scopus 로고
    • Liposomal amphotericin B (AmBisome) in mediterranean visceral leishmaniasis. A multicentre trial
    • Davidson, R.N., Dimartino, L., Gradoni, L. et al. Liposomal amphotericin B (AmBisome) in mediterranean visceral leishmaniasis. A multicentre trial. Q J Med 1994, 87: 75-81.
    • (1994) Q J Med , vol.87 , pp. 75-81
    • Davidson, R.N.1    Dimartino, L.2    Gradoni, L.3
  • 50
    • 0036178457 scopus 로고    scopus 로고
    • AmBisome: Liposomal formulation, structure, mechanism of action and preclinical experience
    • Moore, A., Proffit, R.T. AmBisome: Liposomal formulation, structure, mechanism of action and preclinical experience. J Antimicrob Chemother 2002, 49 (Suppl. 1): 21-30.
    • (2002) J Antimicrob Chemother , vol.49 , Issue.SUPPL. 1 , pp. 21-30
    • Moore, A.1    Proffit, R.T.2
  • 51
    • 0001571784 scopus 로고
    • Usual lipid structures selectively reduce the toxicity of amphetericin B
    • Janoff, A.S., Boni, L.J., Poescu, M.C. et al. Usual lipid structures selectively reduce the toxicity of amphetericin B. Proc Natl Acad Sci USA 1988, 85: 6122-6.
    • (1988) Proc Natl Acad Sci USA , vol.85 , pp. 6122-6126
    • Janoff, A.S.1    Boni, L.J.2    Poescu, M.C.3
  • 52
    • 17344368128 scopus 로고    scopus 로고
    • Amphotericin B lipid complex for invasive fungal infections: Analysis of safety and efficacy in 556 cases
    • Walsh, T.J., Hiemenz, J.W., Seibel, N.L. et al. Amphotericin B lipid complex for invasive fungal infections: Analysis of safety and efficacy in 556 cases. Clin Infect Dis 1998, 26: 1383-96.
    • (1998) Clin Infect Dis , vol.26 , pp. 1383-1396
    • Walsh, T.J.1    Hiemenz, J.W.2    Seibel, N.L.3
  • 53
    • 0001213695 scopus 로고
    • Amphotericin B lipid complex versus amphotericin B for the treatment of hematogenous and invasive candidiasis: A prospective ramdomized multicentre trial
    • San Francisco
    • Anaissie, E.J., White, M., Uzun, O. et al. Amphotericin B lipid complex versus amphotericin B for the treatment of hematogenous and invasive candidiasis: A prospective ramdomized multicentre trial. Proceedings of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco 1995, 330: 17-20.
    • (1995) Proceedings of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy , vol.330 , pp. 17-20
    • Anaissie, E.J.1    White, M.2    Uzun, O.3
  • 54
    • 9044250097 scopus 로고    scopus 로고
    • Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcol meningitis in patients with AIDS
    • Sharkey, P.K., Graybill, J.R., Johnson, E.S. et al. Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcol meningitis in patients with AIDS. Clin Infect Dis 1996, 22: 315-21.
    • (1996) Clin Infect Dis , vol.22 , pp. 315-321
    • Sharkey, P.K.1    Graybill, J.R.2    Johnson, E.S.3
  • 55
    • 0028954312 scopus 로고
    • Amphotericin B lipid complex
    • Fromtling, R.A. Amphotericin B lipid complex. Drugs Fut 1995, 20: 129-34.
    • (1995) Drugs Fut , vol.20 , pp. 129-134
    • Fromtling, R.A.1
  • 56
    • 0023137231 scopus 로고
    • Effect of lipid composition and liposome size on toxicity and in vitro fungicidal activity of liposomal intercalated amphotericin B
    • Szoka, F.C., Miltrolland, D., Barza, M. Effect of lipid composition and liposome size on toxicity and in vitro fungicidal activity of liposomal intercalated amphotericin B. Antimicrob Agents Chemother 1987, 31: 421-9.
    • (1987) Antimicrob Agents Chemother , vol.31 , pp. 421-429
    • Szoka, F.C.1    Miltrolland, D.2    Barza, M.3
  • 57
    • 0028283641 scopus 로고
    • Overview of amphotericin B colloidal dispersion (Amphocil)
    • Stevens, D.A. Overview of amphotericin B colloidal dispersion (Amphocil). J Infact 1994, 28 (Suppl. 1) 45-9.
    • (1994) J Infact , vol.28 , Issue.SUPPL. 1 , pp. 45-49
    • Stevens, D.A.1
  • 58
    • 0033032842 scopus 로고    scopus 로고
    • Safety and efficacy of amphotericin B colloidal dispersion. An overview
    • Herbrecht, R., Letscher, V., Andres, E., Cavalier, A. Safety and efficacy of amphotericin B colloidal dispersion. An overview. Chemotherapy 1999, 45: 67-76.
    • (1999) Chemotherapy , vol.45 , pp. 67-76
    • Herbrecht, R.1    Letscher, V.2    Andres, E.3    Cavalier, A.4
  • 59
    • 0001276697 scopus 로고    scopus 로고
    • Zygomycosis treated with amphotericin B colloidal dispersion. A review of 22 cases
    • Herbrecht, R., Letscher, V., Andres, E., Kusne, S., Gurwith, M., Oberling, F. Zygomycosis treated with amphotericin B colloidal dispersion. A review of 22 cases. Blood 1996, 88: 502a.
    • (1996) Blood , vol.88
    • Herbrecht, R.1    Letscher, V.2    Andres, E.3    Kusne, S.4    Gurwith, M.5    Oberling, F.6
  • 61
    • 7344264567 scopus 로고    scopus 로고
    • Ramdomized, double-blind clinical trial of amphotericin B colloidal dispersion vs. amphotericin B in the empirical treatment of fever and neutropenia
    • White, M.H., Bowden, R.A., Sandler, E.S. et al. Ramdomized, double-blind clinical trial of amphotericin B colloidal dispersion vs. amphotericin B in the empirical treatment of fever and neutropenia. Clin Infect Dis 1998, 27: 296-302.
    • (1998) Clin Infect Dis , vol.27 , pp. 296-302
    • White, M.H.1    Bowden, R.A.2    Sandler, E.S.3
  • 62
    • 0029115636 scopus 로고
    • Population pharmacokinetics and renal function, sparing effects of amphotericin B in colloidal dispersion in patients receiving bone marrow transplants
    • Amantea, M.A., Bowden, R.A., Forest, A., Working P.K., Newman, M.S., Mamclok, R.D. Population pharmacokinetics and renal function, sparing effects of amphotericin B in colloidal dispersion in patients receiving bone marrow transplants. Antimicrob Agents Chemother 1995, 39: 2042-7.
    • (1995) Antimicrob Agents Chemother , vol.39 , pp. 2042-2047
    • Amantea, M.A.1    Bowden, R.A.2    Forest, A.3    Working, P.K.4    Newman, M.S.5    Mamclok, R.D.6
  • 63
    • 0027288083 scopus 로고
    • Amphotericin B cholesterol sulfate complex (colloidal dispersion)
    • Fromting, R.A. Amphotericin B, cholesterol sulfate complex (colloidal dispersion). Drugs Fut 1993, 18: 303-6.
    • (1993) Drugs Fut , vol.18 , pp. 303-306
    • Fromting, R.A.1
  • 64
    • 0023743895 scopus 로고
    • An emulsion formulation of amphotericin B improves the therapeutic index when treating systemic murine candidiasis
    • Krish, R., Goldstein, R., Tarloff, J. et al. An emulsion formulation of amphotericin B improves the therapeutic index when treating systemic murine candidiasis. J Infect Dis 1988, 158: 1065-70.
    • (1988) J Infect Dis , vol.158 , pp. 1065-1070
    • Krish, R.1    Goldstein, R.2    Tarloff, J.3
  • 65
    • 0028123632 scopus 로고
    • In vitro renal toxicity and in-vivo therapeutic efficacy in experimental murine cryptococcosis of amphotericin B (Fungizone) associated with Intralipid
    • Joly, V., Farinotti, R., Saint Julien, L., Cheron, M., Carbon, C., Yeni, P. In vitro renal toxicity and in-vivo therapeutic efficacy in experimental murine cryptococcosis of amphotericin B (Fungizone) associated with Intralipid. Antimicrob Agents Chemother 1994, 38: 177-83.
    • (1994) Antimicrob Agents Chemother , vol.38 , pp. 177-183
    • Joly, V.1    Farinotti, R.2    Saint Julien, L.3    Cheron, M.4    Carbon, C.5    Yeni, P.6
  • 66
    • 0027478044 scopus 로고
    • Effficacy and tolerance of an amphotericin B lipid (intralipid) emulsion in the treatment of candidaemia in neutropenic patients
    • Caillot, D., Casasnovas, O., Solary, E. et al. Effficacy and tolerance of an amphotericin B lipid (intralipid) emulsion in the treatment of candidaemia in neutropenic patients. J Antimicrob Chemother 1993, 31: 161-9.
    • (1993) J Antimicrob Chemother , vol.31 , pp. 161-169
    • Caillot, D.1    Casasnovas, O.2    Solary, E.3
  • 67
    • 0026658704 scopus 로고
    • Clinical evaluation of a new lipid based delivery system for intravenous administration of amphotericin B
    • Caillot, D., Charanet, R., Casasnovas, O. et al. Clinical evaluation of a new lipid based delivery system for intravenous administration of amphotericin B. Eur J Clin Microbiol Infect Dis 1992, 11: 722-5.
    • (1992) Eur J Clin Microbiol Infect Dis , vol.11 , pp. 722-725
    • Caillot, D.1    Charanet, R.2    Casasnovas, O.3
  • 68
    • 0026452250 scopus 로고
    • Reduced renal toxicity and improved clinical tolerance of amphotericin B mixed with Intralipid compared with conventional amphotericin B in neutropenic patients
    • Moreau, P., Milpied, N., Fayette, N., Ramee, J.F., Harousseau, J.L. Reduced renal toxicity and improved clinical tolerance of amphotericin B mixed with Intralipid compared with conventional amphotericin B in neutropenic patients. J Antimicrob Chemother 1992, 30: 535-41.
    • (1992) J Antimicrob Chemother , vol.30 , pp. 535-541
    • Moreau, P.1    Milpied, N.2    Fayette, N.3    Ramee, J.F.4    Harousseau, J.L.5
  • 70
    • 0033895538 scopus 로고    scopus 로고
    • Attentuation of nephrotoxicity by a novel lipid nanosphere (NS-718) incorporating amphotericin B
    • Hossain, M.A., Maesaki, S., Razzaque, M.S., Tomono, K., Taguchi, T., Kohno, S. Attentuation of nephrotoxicity by a novel lipid nanosphere (NS-718) incorporating amphotericin B. J Antimicrob Chemother 2000, 46: 263-8.
    • (2000) J Antimicrob Chemother , vol.46 , pp. 263-268
    • Hossain, M.A.1    Maesaki, S.2    Razzaque, M.S.3    Tomono, K.4    Taguchi, T.5    Kohno, S.6
  • 72
    • 0036241196 scopus 로고    scopus 로고
    • Lipid formulation as a drug carrier for drug delivery
    • Tomii, Y. Lipid formulation as a drug carrier for drug delivery. Curr Pharm Des 2002, 8: 467-74.
    • (2002) Curr Pharm Des , vol.8 , pp. 467-474
    • Tomii, Y.1
  • 75
    • 0028353627 scopus 로고
    • Administering amphotericin B - A practical approach
    • Khoo, S.H., Bond, J., Denning, D.W. Administering amphotericin B - A practical approach. J Antimicrob Chemother 1994, 33: 203-13.
    • (1994) J Antimicrob Chemother , vol.33 , pp. 203-213
    • Khoo, S.H.1    Bond, J.2    Denning, D.W.3
  • 76
    • 0020663457 scopus 로고
    • Clinical pharmacokinetics of systemic antifungal drugs
    • Daneshmend, T.K., Warnock, D.W. Clinical pharmacokinetics of systemic antifungal drugs. Clin Pharmacokinet 1983, 8: 17-42.
    • (1983) Clin Pharmacokinet , vol.8 , pp. 17-42
    • Daneshmend, T.K.1    Warnock, D.W.2
  • 77
    • 0025877789 scopus 로고
    • Amphotericin B lipid complex therapy of experimental fungal infections in mice
    • Clark, J.M., Whitney, R.R., Olsen, S.J. et al. Amphotericin B lipid complex therapy of experimental fungal infections in mice. Antimicrob Agents Chemother 1991, 35: 615-21.
    • (1991) Antimicrob Agents Chemother , vol.35 , pp. 615-621
    • Clark, J.M.1    Whitney, R.R.2    Olsen, S.J.3
  • 78
    • 0026043820 scopus 로고
    • Pharmacology and toxicology of a liposomal formulation of amphotericin B (AmBisome) in rodents
    • Proffitt, R.T., Satorius, A., Chiang, S.M., Sullivan, L., Adler-Moore, J.P. Pharmacology and toxicology of a liposomal formulation of amphotericin B (AmBisome) in rodents. J Antimicrob Chemother 1991, 28 (Suppl. B): 49-61.
    • (1991) J Antimicrob Chemother , vol.28 , Issue.SUPPL. B , pp. 49-61
    • Proffitt, R.T.1    Satorius, A.2    Chiang, S.M.3    Sullivan, L.4    Adler-Moore, J.P.5
  • 79
    • 0028266748 scopus 로고
    • Pharmacokinetics and safety of a unilamellar liposomal formulation of amphotericin B (AmBisome) in rabbits
    • Lee, J.W., Amantea, M.A., Francis, A. et al. Pharmacokinetics and safety of a unilamellar liposomal formulation of amphotericin B (AmBisome) in rabbits. Antimicrob Agents Chemother 1994, 38: 113-8.
    • (1994) Antimicrob Agents Chemother , vol.38 , pp. 113-118
    • Lee, J.W.1    Amantea, M.A.2    Francis, A.3
  • 80
    • 0025300339 scopus 로고
    • Liposomal amphotericin B (AmBisome) treatment in solid organ and bone marrow transplant recipients: Efficacy and safety evaluation
    • Tollernar, J., Ringden, O., Tyden, G. Liposomal amphotericin B (AmBisome) treatment in solid organ and bone marrow transplant recipients: Efficacy and safety evaluation. Clin Transplant 1990, 4: 167-75.
    • (1990) Clin Transplant , vol.4 , pp. 167-175
    • Tollernar, J.1    Ringden, O.2    Tyden, G.3
  • 81
    • 0036167883 scopus 로고    scopus 로고
    • Pharmacokinetics, excretion, and mass balance of liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate in humans
    • Bekersky, I., Fieldiny, R.M., Dressler, D.E., Lee, J.W., Buell, D.N., Walsh, T.J. Pharmacokinetics, excretion, and mass balance of liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate in humans. Antimicrob Agents Chemother 2002, 46: 828-33.
    • (2002) Antimicrob Agents Chemother , vol.46 , pp. 828-833
    • Bekersky, I.1    Fieldiny, R.M.2    Dressler, D.E.3    Lee, J.W.4    Buell, D.N.5    Walsh, T.J.6
  • 82
    • 0025816499 scopus 로고
    • Comparative safety, tolerance and pharmacokinetics of amphotericin B lipid complex and amphotericin B deoxycholate in healthy male volunteers
    • Kan, V.L., Bennett, L.E., Amantea, M.A. et al. Comparative safety, tolerance and pharmacokinetics of amphotericin B lipid complex and amphotericin B deoxycholate in healthy male volunteers. J Infect Dis 1991, 164: 418-25.
    • (1991) J Infect Dis , vol.164 , pp. 418-425
    • Kan, V.L.1    Bennett, L.E.2    Amantea, M.A.3
  • 83
    • 0026002361 scopus 로고
    • Tissue distribution of amphotericin B lipid complex in laboratory animals
    • Olsen, S.J., Swerdel, M.R., Blue, B., Clark, J.M., Bonner, D.P. Tissue distribution of amphotericin B lipid complex in laboratory animals. J Pharm Pharmacol 1991, 43: 831-5.
    • (1991) J Pharm Pharmacol , vol.43 , pp. 831-835
    • Olsen, S.J.1    Swerdel, M.R.2    Blue, B.3    Clark, J.M.4    Bonner, D.P.5
  • 84
    • 0029828007 scopus 로고    scopus 로고
    • Amphotericin B lipid complex: Review of safety, pharmacokinetic and efficacy
    • Dix, S.P., Wingard, J.R. Amphotericin B lipid complex: Review of safety, pharmacokinetic and efficacy. Drugs Today 1996, 32 (Suppl. G): 19-25.
    • (1996) Drugs Today , vol.32 , Issue.SUPPL. G , pp. 19-25
    • Dix, S.P.1    Wingard, J.R.2
  • 85
    • 0025773798 scopus 로고
    • Novel antifungal drug delivery: Stable amphotericin B-cholesteryl sulfate discs
    • Guo, L.S., Fielding, R., Lasic, D.D., Hamilton, R.L., Mufson, D. Novel antifungal drug delivery: Stable amphotericin B-cholesteryl sulfate discs. Int J Pharmaceutics 1991, 75: 45-54.
    • (1991) Int J Pharmaceutics , vol.75 , pp. 45-54
    • Guo, L.S.1    Fielding, R.2    Lasic, D.D.3    Hamilton, R.L.4    Mufson, D.5
  • 86
    • 0026595038 scopus 로고
    • Relationship of pharmacokinetics and drug disribution in tissue to increased safety of amphotericin B colloidal dispersion in dogs
    • Fielding, R., Singer, A., Wang, L., Babbar, S., Gud, L. Relationship of pharmacokinetics and drug disribution in tissue to increased safety of amphotericin B colloidal dispersion in dogs. Antimicrob Agents Chemother 1992, 36: 299-307.
    • (1992) Antimicrob Agents Chemother , vol.36 , pp. 299-307
    • Fielding, R.1    Singer, A.2    Wang, L.3    Babbar, S.4    Gud, L.5
  • 87
    • 0028932001 scopus 로고
    • Comparative tissue distribution and elimination of amphotericin B colloidal dispersion (Amphocil) and fungizone after repeated dosing in rats
    • Wang, L.H., Fielding, R.M., Smith, P.C., Guo, L.S. Comparative tissue distribution and elimination of amphotericin B colloidal dispersion (Amphocil) and fungizone after repeated dosing in rats. Pharm Res 1995, 12: 275-83.
    • (1995) Pharm Res , vol.12 , pp. 275-283
    • Wang, L.H.1    Fielding, R.M.2    Smith, P.C.3    Guo, L.S.4
  • 89
    • 0025845362 scopus 로고
    • Single-dose pharmacokinetics and tolerance of a cholesteryl sulfate complex of amphotericin B administered to healthy volunteers
    • Sanders, S.W., Buchi, K.N., Goddard, M.S., Lany, J.K., Tolman, K.G. Single-dose pharmacokinetics and tolerance of a cholesteryl sulfate complex of amphotericin B administered to healthy volunteers. Antimicrob Agents Chemother 1991, 35: 1029-34.
    • (1991) Antimicrob Agents Chemother , vol.35 , pp. 1029-1034
    • Sanders, S.W.1    Buchi, K.N.2    Goddard, M.S.3    Lany, J.K.4    Tolman, K.G.5
  • 90
    • 0036237750 scopus 로고    scopus 로고
    • In vitro and in vivo antifungal activities of TAK-456, a novel oral triazole with a broad antifungal spectrum
    • Tsuchimori, N., Hayashi, R., Kitamoto, N. et al. In vitro and in vivo antifungal activities of TAK-456, a novel oral triazole with a broad antifungal spectrum. Antimicrob Agents Chemother 2002, 46: 1388-93.
    • (2002) Antimicrob Agents Chemother , vol.46 , pp. 1388-1393
    • Tsuchimori, N.1    Hayashi, R.2    Kitamoto, N.3
  • 91
    • 0036090563 scopus 로고    scopus 로고
    • In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of candida
    • Pfaller, M.A., Messer, S.A., Hollis, R.J., Jones, R.N., Diekema, D.J. In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of candida. Antimicrob Agents Chemother 2002, 46: 1723-7.
    • (2002) Antimicrob Agents Chemother , vol.46 , pp. 1723-1727
    • Pfaller, M.A.1    Messer, S.A.2    Hollis, R.J.3    Jones, R.N.4    Diekema, D.J.5
  • 92
    • 0344837276 scopus 로고    scopus 로고
    • Yatakemycin, a novel antifungal antibiotic produced by Streptomyces. TP-A0356
    • Igarashi, Y., Futamata, K., Fujita, T. et al. Yatakemycin, a novel antifungal antibiotic produced by Streptomyces. TP-A0356. J Antibiot 2003, 56: 107-13.
    • (2003) J Antibiot , vol.56 , pp. 107-113
    • Igarashi, Y.1    Futamata, K.2    Fujita, T.3
  • 93
    • 0036146358 scopus 로고    scopus 로고
    • In vitro and in vivo activities of CS-758 (R-120758), a new triazole antifungal agent
    • Yasuki, K., Tamako, H., Takashi, F. et al. In vitro and in vivo activities of CS-758 (R-120758), a new triazole antifungal agent. Antimicrob Agents Chemother 2002, 46: 367-70.
    • (2002) Antimicrob Agents Chemother , vol.46 , pp. 367-370
    • Yasuki, K.1    Tamako, H.2    Takashi, F.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.